Scarica l'app Stockscreener
8.81
4.88%
0.41
Pre-mercato:
8.72
-0.09
-1.02%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché NVAX Giù?
Forum
Previsione
Frazionamento azionario
Novavax Inc Borsa (NVAX) Ultime notizie
Novavax Inc. stock outperforms competitors on strong trading day - MarketWatch
Novavax, Inc. (NASDAQ:NVAX) Receives $17.83 Average PT from Analysts - MarketBeat
Novavax, Inc. (NVAX) Stock: The Under-the-Radar Stock Poised for Massive Upside in 2025 - Insider Monkey
10 Under-the-Radar Stocks with Massive Upside for 2025 - Insider Monkey
Novavax climbs as FDA lifts clinical hold on Covid, flu combo trials - MSN
Analysts Set Novavax, Inc. (NASDAQ:NVAX) PT at $17.83 - MarketBeat
Retail Investors Bet On Anavex Lifesciences Stock To Outperform Novavax, Rigel Pharma In Q1 On Alzheimer’s Drug Buzz - MSN
Novavax Inc. stock underperforms Friday when compared to competitors - MarketWatch
Bird Flu Raising Red Flags Among Health Officials, CDC Urges Faster Testing - Benzinga
Moderna Dropped by 20% This Week -- Is It a Smart Buy Right Now? - The Motley Fool
Novavax Cashes In On Its COVID Albatross -- Challenges Remain (Rating Upgrade) - Seeking Alpha
Novavax (NVAX) Rises But Trails Market: What Investors Should Know - Yahoo Finance
Novavax Inc. stock underperforms Monday when compared to competitors - MarketWatch
Novavax Slips 7.3% After 2024 Revenue Guidance Reaffirmed - MarketWatch
Looking Into Novavax's Recent Short Interest - Benzinga
Why Novavax (NVAX) Stock Is Falling - Benzinga
Novavax: presents its 2025 growth strategy - Marketscreener.com
Novavax Shares Strategic Updates at Healthcare Conference - TipRanks
We Asked Retail If Novavax Stock Is A Buy At Current Levels: Nearly 70% Think It's Undervalued - MSN
Novavax to complete data submission to FDA by end of the year for authorization of its coronavirus vaccine - WPSD Local 6
(NVAX) On The My Stocks Page - Stock Traders Daily
Why Novavax Stock Is Volatile This Week - Benzinga
Novavax Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
Novavax (NASDAQ:NVAX) Stock Price Down 8.2%Time to Sell? - MarketBeat
Bird Flu Sparks Vaccine Stock Surge: ETFs To Watch As H5N1 Outbreak Intensifies - Benzinga
Novavax, Inc. (NVAX) is Attracting Investor Attention: Here is What You Should Know - Yahoo Finance
Novavax (NASDAQ:NVAX) surges 35% this week, taking five-year gains to 171% - Yahoo Finance
Strength Seen in Novavax (NVAX): Can Its 10.9% Jump Turn into More Strength? - MSN
Vaccine Stocks Jump After CDC Reports First US Bird-Flu Death - Yahoo Finance
Health Care Up as Vaccine Makers Surge -- Health Care Roundup - Marketscreener.com
Moderna, BioNTech, Novavax Surge After CDC Reports Two-Week Covid Spike - Yahoo! Voices
Options Alert: Why Novavax (NVAX) Could Be The Biotech Hero Of Trump 2.0 - Barchart
Novavax (NASDAQ:NVAX) Sees Large Volume IncreaseShould You Buy? - MarketBeat
Novavax Target of Unusually High Options Trading (NASDAQ:NVAX) - MarketBeat
Moderna, Novavax Stocks Climb Pre-Market On Growing Bird Flu Concerns: Retail Engagement Soars - MSN
US Records First Human Bird Flu Death, High Levels Of Respiratory Illnesses: Vaccine Stocks Rally - Benzinga
Novavax (NVAX) Shares Cross Above 200 DMA - Nasdaq
Moderna, Novavax and other vaccine names extend gains amid COVID/flu concerns - Seeking Alpha
Why Novavax (NVAX) Stock Is Rising - Benzinga
Insiders At Novavax Sold US$713k Of Stock Potentially Indicating Weakness - Simply Wall St
Novavax Lowers 2024 Forecast Despite Q3 Revenue Beat, Stock Falls - AOL
Insider Sell: James Young Sells 10,000 Shares of Novavax Inc (NV - GuruFocus.com
Novavax, Inc. (NASDAQ:NVAX) Director James F. Young Sells 4,600 Shares - MarketBeat
Novavax, Inc. (NASDAQ:NVAX) Director James F. Young Sells 5,400 Shares - MarketBeat
Novavax, Inc. (NASDAQ:NVAX) Director Rachel K. King Sells 4,150 Shares - MarketBeat
Novavax director Rachel King sells $37,435 in stock - Investing.com
Novavax director James Young sells shares worth $82,208 - Investing.com
Novavax director Rachel King sells $37,435 in stock By Investing.com - Investing.com UK
Novavax (NASDAQ:NVAX) Trading Up 6.6%Still a Buy? - MarketBeat
NVAX February 14th Options Begin Trading - Nasdaq
Novavax completes $200 million facility sale to Novo Nordisk By Investing.com - Investing.com Australia
Novavax completes $200 million facility sale to Novo Nordisk - Investing.com
Where are the Opportunities in (NVAX) - Stock Traders Daily
4.81%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):